Virtici is recruiting postdoctoral fellows with a strong interest in product development and commercialization of therapeutics. Our Product Commercialization Internship program is designed to help develop the skills and experience necessary for developing a successful career in both academic and industry. Interns will be assigned to work on a specific project and become a key driver in product positioning, conducting market research, developing the product development strategy, and helping support funding opportunities.


  •     Ph.D. and/or M.D. degree
  •      Currently a postdoctoral fellow in the biomedical sciences
  •      Strong written and verbal communication skills
  •      Ability to work both independently and collaboratively
  •        Interest to explore new scientific areas 

Internship Details:

  •       Internships are expected to last 1 year
  •       Must commit on average of 10 hours per week
  •       Interns will report directly to Virtici scientists and management
  •       Interns will be matched with projects according to interest and experience


  •       Gain experience working in the industry to add to your resume and/or portfolio.
  •       Receive mentorship from seasoned entrepreneurs and business executives experienced in therapeutic product development.
  •       Expand professional network with leading academic innovators and global biotechnology and pharmaceutical partners.


To apply, please send a cover letter and a resume to



About Virtici

Virtici is a product development company focused on improving the way we treat disease and manage pain. Virtici partners with leading investigators and their respective research institutions to commercialize innovations with the greatest market potential, providing the business and finance expertise to accelerate product development. Virtici improves healthcare through added efficiencies and innovation, and connects all aspects of product development by working closely with our academic collaborators, affiliates in Boston, MA (Celdara Medical) and Indianapolis, IN (MBV), and pipeline development partners Daiichi Sankyo and Grünenthal Group.